Dobutamine and Nitroglycerine versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery

Not Applicable

• Conditions: Surgery; anesthesia; Anaesthesia

• Registration Number: PACTR201710002685398
• Lead Sponsor: menoufiya faculty of medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-12
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Other
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

The inclusion criteria were patients with mitral valve disease aged between 22 to 45 years old of both sexes having PAP ranged from 65 to 110 mmHg and scheduled for elective mitral valve replacement.

Exclusion Criteria

The Exclusion criteria were patients with Severely reduced myocardial function i.e. left ventricular ejection fraction <45%, Severe liver insufficiency, Renal insufficiency (serum creatinine >2.0 mmol/L), Severe chest disease or COPD patients, Pulmonary valve disease or replacement, Recent pacemaker insertion, left bundle branch block, Wolf Parkinson-White Syndrome or Ebstein¿s anomaly and Recent stroke.

Study & Design

• Study Type: Interventional
• Study Design: Not specified